The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is rapidly infecting people worldwide, resulting in the infectious disease coronavirus disease 19 (COVID-19) that has been declared a pandemic. Much remains unknown about COVID-19, including its effects on solid organ transplant (SOT) recipients. Given their immunosuppressed state, SOT recipients are presumed to be at high risk of complications with viral infections such as SARS-CoV-2. Limited case reports in single SOT recipients, however, have not suggested a particularly severe course in this population. In this report, we present a dual-organ (heart/kidney) transplant recipient who was found to have COVID-19 and, despite the presence of a number of risk factors for poor outcomes, had a relatively mild clinical course.
Keywords: biomarker; clinical research/practice; diabetes: type 2; graft survival; heart transplantation/cardiology; immunosuppressive regimens - minimization/withdrawal; infection and infectious agents - viral; infectious disease; kidney transplantation/nephrology.
© 2020 The American Society of Transplantation and the American Society of Transplant Surgeons.